Xenetic Biosciences Inc (XBIO) — Cash Flow Reinvestment Rate

Latest as of December 2017: 0.00x

Xenetic Biosciences Inc (XBIO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2017, reinvesting $9.00K (capex $9.00K ) from operating cash flow of $4.84 Million. Check XBIO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$9.00K
Capex + Investments

Operating Cash Flow

$4.84 Million
USD

Capital Expenditures

$9.00K
USD

Xenetic Biosciences Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Xenetic Biosciences Inc across 1 annual periods. Explore cash flow to debt ratio of Xenetic Biosciences Inc to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Xenetic Biosciences Inc (2017–2017)

Year-by-year capital reinvestment analysis for Xenetic Biosciences Inc. For live market cap and broader valuation context, see XBIO market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 0.01x $18.53K $1.49 Million $9.26K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow